Limberg Trial

Het verschil in wondgenezing tussen Limberg-plastiek en primair sluiten in de midline na excisie sinus pilonidalis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON22628

Enrollment

Registered

2014-11-18

Start date

2015-01-01

Completion date

Unknown

Last updated

2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Limbergplastiek vs. sluiten in midline na excisie sinus pilonidalis

Eligibility

Inclusion criteria

Inclusion criteria: primary or recurrent pilonidal sinus width of fistulacomplex between 1 and 3 centimeter signed informed consent age: >/= 18 years mentally competent

Exclusion criteria

Exclusion criteria: patients with an actual abscess not able to follow-up patients in which woundhealing problems are to be expected (Diabetes type II, immunesupression, chemotherapy, HIV/AIDS) not mentally competent dementia

Design outcomes

Primary

Measure	Time frame
Tijd tot volledige wondgenezing	—

Secondary

Measure	Time frame
Het aantal wondinfecties, het recidiefpercentage binnen 1 jaar, en een aantal factoren die de morbiditeit na de operatie bepalen zullen worden onderzocht.	—

Contacts

Public ContactA. Stam

Medisch Spectrum Twente Postbus 50000

researchbureau.heelkunde@ziekenhuis-mst.nl

Outcome results